Brian Park, PharmD

Drug Information Specialist https://www.clinicaladvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Infectious Diseases Information Center

CDC: Fully Vaccinated Can Now Go Maskless With Some Exceptions

Brian Park, PharmD

May 13, 2021

Fully vaccinated individuals may resume indoor and outdoor activities without wearing masks or physical distancing, except under certain circumstances.

Psychiatry Information Center

Evekeo ODT Approved for Younger Patients With ADHD

Brian Park, PharmD

April 28, 2021

Evekeo ODT, a Schedule II controlled substance, contains a 1:1 racemic mixture of dextroamphetamine sulfate and levoamphetamine sulfate.

Cardiovascular Disease Information Center

Diovan Approved for Younger Patients With Hypertension

Brian Park, PharmD

April 28, 2021

The approval was based on data from 3 clinical studies that assessed the antihypertensive effect of valsartan in 290 children 1 to less than 6 years of age.

ADHD Information Center, News

Qelbree, a Nonstimulant Treatment for ADHD, Gets FDA Approval

Brian Park, PharmD

April 6, 2021

The approval was based on data from an extensive development program that included four phase 3 studies involving more than 1000 patients 6 to 17 years of age.

Infectious Diseases Information Center

Trial Evaluating Tocilizumab Plus Remdesivir for COVID-19 Pneumonia Misses End Points

Brian Park, PharmD

March 15, 2021

The REMDACTA study evaluated the efficacy and safety of tocilizumab plus remdesivir in hospitalized patients with severe COVID-19 pneumonia receiving standard of care.

Ob/Gyn Information Center

Fezolinetant Reduces Vasomotor Symptoms Associated With Menopause

Brian Park, PharmD

March 3, 2021

Fezolinetant is designed to reduce the frequency and severity of VMS associated with menopause by inhibiting neurokinin B binding on the kisspeptin/neurokinin/dynorphin neuron.

Vaccine Information Center

Pfizer-BioNTech COVID-19 Vaccine: New Storage Conditions Approved; Booster Dose Study Initiated

Brian Park, PharmD

February 26, 2021

Previously, the labeling stated that the undiluted vials must be stored in an ultra-low temperature freezer.

Vaccine Information Center

Tick-Borne Encephalitis Vaccine Gets Priority Review

Brian Park, PharmD

February 26, 2021

TicoVac is an inactivated whole virus vaccine developed using a master ‘seed’ virus that is similar to the tick-borne encephalitis virus found in nature.

Investigational meningococcal vaccine may protect patients during outbreak

Pediatrics Information Center

ACIP: 2021 Child and Adolescent Immunization Schedule Updates

Brian Park, PharmD

February 19, 2021

Fewer childhood vaccines have been administered due to a decline in outpatient pediatric visits resulting from the COVID-19 pandemic.

Pediatrics Information Center

Nerivio Device Cleared for Migraine in Adolescents

Brian Park, PharmD

February 1, 2021

The approval was based on data from an open-label, single-arm study that evaluated the efficacy and safety of Nerivio in patients aged 12 to 17 years with migraine.

Next post in Pediatrics Information Center